VYNE Therapeutics Inc.·4

Jul 5, 5:01 PM ET

Zeronda Tyler 4

4 · VYNE Therapeutics Inc. · Filed Jul 5, 2022

Insider Transaction Report

Form 4
Period: 2022-06-30
Zeronda Tyler
CHIEF FINANCIAL OFFICER
Transactions
  • Tax Payment

    Common Stock

    2022-06-30$0.39/sh354$138173,712 total
Footnotes (1)
  • [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION